Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,805
Closed -$3.12M 84
2021
Q2
$3.12M Buy
12,805
+910
+8% +$224K 0.92% 44
2021
Q1
$2.96M Buy
11,895
+137
+1% +$32.7K 0.96% 44
2020
Q4
$2.92M Buy
11,758
+886
+8% +$204K 1.69% 30
2020
Q3
$2.76M Sell
10,872
-196
-2% -$48.6K 1.96% 29
2020
Q2
$2.61M Sell
11,068
-671
-6% -$153K 1.96% 28
2020
Q1
$2.38M Buy
11,739
+255
+2% +$55.7K 1.59% 27
2019
Q4
$2.77M Buy
11,484
+864
+8% +$190K 1.72% 32
2019
Q3
$2.06M Buy
+10,620
New +$2.04M 1.37% 34

Other funds holding AMGN

Unified Trust Company's AMGN Position: Q3 2021 in Review

Unified Trust Company sold out of Amgen (AMGN) in Q3 2021, closing a stake of 12,805 shares — an estimated $3.12M sold.

Unified Trust Company first reported a position in AMGN in Q3 2019 and held it in 8 quarters. The position peaked at $3.12M in Q2 2021. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Unified Trust Company reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Unified Trust Company sold 12,805 Amgen shares in Q3 2021, an estimated $3.12M.
  • Unified Trust Company first reported a position in Amgen in Q3 2019 and held it in 8 quarters.
  • Unified Trust Company's Amgen position peaked at $3.12M in Q2 2021.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Unified Trust Company's 13F filing for Q3 2021, filed 23 Nov 2021.